376
Participants
Start Date
May 27, 2021
Primary Completion Date
August 15, 2024
Study Completion Date
March 26, 2025
Experimental: Interventional Cohort: TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System
Standard of Care Surgery + Embolization
Standard of Care Surgery
Standard of Care Surgery Only
Experimental: Interventional Cohort: TRUFILL n-BCA Liquid Embolic System
Standard of Care Medical Management + Embolization
Standard of Care Medical Management
Standard of Care Medical Management Only
Mount Sinai Hospital, New York
Westchester Medical Center, Valhalla
Allegheny General Hospital of Research, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
George Washington University, Washington D.C.
University of Maryland, Baltimore
University of Virginia School of Medicine, Charlottesville
West Virginia Hospital, Morgantown
Duke University Medical Center, Durham
Wellstar Health System, Marietta
Piedmont Hospital, Atlanta
Memorial Health University Health Center, Savannah
Baptist Medical Center, Jacksonville
Advent Health Orlando, Orlando
University of Miami - Jackson Memorial Hospital, Miami
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Semmes Murphey Foundation, Memphis
Ohio Health, Columbus
Mercy Health St Vincent Medical Center, Toledo
University of Cincinnati, Cincinnati
University of Minnesota, Minneapolis
Texas Stroke Institute, Plano
Swedish Medical Center, Englewood
University of Utah, Salt Lake City
Carondelet St Joseph's Hospital, Tucson
John Muir Physician Network Clinical Research Center, Walnut Creek
Oregon Health and Science University, Portland
Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing
Hartford Hospital, Hartford
Yale University, New Haven
Lahey Hospital & Medical Center, Burlington
Cerenovus, Part of DePuy Synthes Products, Inc.
INDUSTRY